DOSTINEX Tablets Ref.[6471] Active ingredients: Cabergoline

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2016  Publisher: Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9JN

Product name and form

Dostinex 0.5 mg Tablets.

Pharmaceutical Form

Tablet.

Flat, capsule-shaped, 4 × 8 mm, scored, white tablets.

Qualitative and quantitative composition

One Dostinex tablet contains 0.5 mg cabergoline.

Excipients with known effect: Each tablet contains 75.90 mg of lactose.

For the full list of excipients, see section 6.1.

Active Ingredient
Description
Cabergoline
List of Excipients

Lactose
Leucine

Pack sizes and marketing

Class I amber glass bottles, stoppered with an aluminum tamper-evident screw cap with silica gel insert or high-density polyethylene (HDPE) bottles with child-resistant polypropylene (PP) cap with inner low-density polyethylene (LDPE) desiccant canister containing silica gel.

Each bottle contains 2, 4 or 8 tablets and is enclosed in an outer cardboard carton.

Not all pack sizes may be marketed.

Marketing authorization holder

Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9JN

Marketing authorization dates and numbers

PL 00057/0969

24 June 2002

Drugs

Drug
Countries
DOSTINEX
Austria, Australia, Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Italy, Lithuania, Malta, Mexico, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈